Literature DB >> 4177546

A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism.

E J Lappat, M J Cawein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4177546     DOI： 10.1016/0002-9343(68)90183-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

1.  A new sustained-release tablet formulation of procainamide.

Authors:  D Fremstad; S Dahl; S Jacobsen; P K Lunde; K J Nådland; A A Marthinsen; T Waaler; K H Landmark
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

2.  Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).

Authors:  J H ten Veen; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

Review 3.  Drug eruptions.

Authors:  P C Newbold
Journal:  Calif Med       Date:  1970-07

4.  Procainamide-induced systemic lupus erythematosus.

Authors:  P J Sheldon; W R Williams
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

5.  Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.

Authors:  D Alarcón-Segovia; E Fishbein; V M Betancourt
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

Review 6.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.